Spencer Torgan, Financial Advisor at Morgan Stanley

Home
United States
Westlake Village, CA
Spencer Torgan, Financial Advisor at Morgan Stanley

Call Directions Website Contact the business

Financial Advisor at Morgan Stanley MSSB will not accept page purchase or sale orders via social network messaging systems.

©2026 Morgan Stanley Smith Barney LLC (‘MSSB’), Member SIPC (www.sipc.org), reserves the right, under applicable law, to retain and monitor all electronic communications. MSSB is not responsible for content posted by third-parties. MSSB does not provide tax or legal advice. MSSB Financial Advisors may only transact business, provide individualized responses, or render personalized investment advice for compensation in states where they are registered or excluded or exempted from registration https://brokercheck.finra.org/. Designations or awards are not indicative of a Financial Advisor's past or future performance, and no fee is paid in exchange for such. The information on this profile does not provide personalized investment advice and is not an offer to buy or sell any security, open a particular account, or to engage in any investment strategy. All content is for US residents only and subject to the following terms: http://www.morganstanley.com/disclaimers/mswm-email.html, https://www.morganstanley.com/disclosures/social-media-important-information.

10/30/2026

US equities fell sharply Friday, with the S&P 500 posting its worst day since June, as investors faced deepening anxiety over the AI trade. Read more in the 1% Move report.

morganstanley.com

10/23/2026

$40 billion today.

$2.3 trillion by 2030.

That's the projected growth path for tokenized real-world assets, according to Morgan Stanley Research.

It's one of two technology shifts the report says could widen the gap between winners and laggards in asset and wealth management.

What's the other one? And what separates the firms that break away?

Find out here:

morganstanley.com

10/22/2026

The S&P 500 closed lower Thursday, as investors weighed concerns on the size of the AI capital expenditure buildout. Read more in the 1% move report.

morganstanley.com

10/21/2026

Most investors get that AI is changing software. But what happens when AI starts interacting with the physical world?

Morgan Stanley Research estimates AI robotics could become a $25 trillion annual revenue opportunity by 2050.

That's the focus of The Robot Almanac, a multi-part video series exploring the technologies, adoption trends, and opportunities shaping the next phase of AI growth.

Follow along as our Chief Robot Strategist, Adam Jonas, examines where this shift may be headed and what investors should be watching.
https://livesocial.seismic.com/qCk6c

10/16/2026

US equities retreated Friday as elevated financing costs amplified concerns surrounding return on investment from the AI capex buildout. Read more in the 1% Move report.

morganstanley.com

10/15/2026

US equities fell sharply on Wednesday, as a hotter-than-expected September CPI report prompted a hawkish repricing of near-term expectations for Fed policy. Read more in the 1% Move report:

morganstanley.com

10/09/2026

The AI era is moving into the physical world—and Morgan Stanley Research is helping investors understand what comes next.

In The Robot Almanac, Morgan Stanley's new 8-part video series, we explore robotics, physical AI, and the market forces that could reshape the global economy. Our forecast: the AI robotics market could reach $25 trillion in annual product revenues by 2050.

Watch the first episode: https://livesocial.seismic.com/aKd050

These trends raise important questions for portfolios and long-term investment strategy. Are you ready? Let's talk about what this next wave of innovation could mean for you.

09/21/2026

US equities climbed Monday as signs of US-Iran diplomacy helped to ease oil prices, in turn curbing inflationary concerns. Read more in the 1% Move report.

morganstanley.com

09/17/2026

US equities rose, as lower oil prices helped ease inflationary concerns. Read More in the 1% Move report.

morganstanley.com

09/17/2026

Biotech is entering a very different chapter.

The story is no longer just about breakthrough science. It's about which innovations can scale, get funded, navigate regulation, and reshape how care is delivered.

One compelling signal: advances across areas like AI-enabled drug discovery, precision medicine, and next-generation therapies are changing the pace and economics of healthcare innovation.

For investors, the important question isn't simply "what's promising?"

It's what the next wave of biotech may reveal about productivity, access, commercialization, and long-term healthcare transformation.

This Morgan Stanley piece offers a timely look at the trends pushing the industry forward, and why the market may be paying close attention.

Read the full article for the bigger picture.

morganstanley.com

Address

2829 Townsgate Road Suite 200
Westlake Village, CA
91361

Telephone

+18054740285

Website

https://advisor.morganstanley.com/spencer.torgan

Alerts

Be the first to know and let us send you an email when Spencer Torgan, Financial Advisor at Morgan Stanley posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.